CONMED Corporation
CNMD
$57.08
-$0.67-1.16%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -7.14% | 9.23% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.14% | 9.23% | |||
| Cost of Revenue | -5.08% | 7.18% | |||
| Gross Profit | -8.67% | 10.81% | |||
| SG&A Expenses | 10.22% | 3.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.95% | 5.11% | |||
| Operating Income | -56.54% | 38.87% | |||
| Income Before Tax | -82.42% | -22.70% | |||
| Income Tax Expenses | -83.45% | 32.34% | |||
| Earnings from Continuing Operations | -82.12% | -31.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -82.12% | -31.09% | |||
| EBIT | -56.54% | 38.87% | |||
| EBITDA | -40.86% | 24.13% | |||
| EPS Basic | -82.15% | -31.24% | |||
| Normalized Basic EPS | -66.49% | 52.10% | |||
| EPS Diluted | -82.41% | -31.19% | |||
| Normalized Diluted EPS | -66.43% | 52.26% | |||
| Average Basic Shares Outstanding | 0.16% | 0.22% | |||
| Average Diluted Shares Outstanding | 0.02% | 0.11% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 4.60% | 0.45% | |||